Altamira Therapeutics Ltd. Proportion Of Ownership Interest In Subsidiary
Altamira Therapeutics Ltd. (CYTOF) reported Proportion Of Ownership Interest In Subsidiary of 49.00% for the 6-month period ending 2024-06-30, per its 6-K filed 2024-09-24.
Financial Statements › Notes
ifrs-full:ProportionOfOwnershipInterestInSubsidiary · last filed 2025-04-30
- 2024-06-30: Proportion Of Ownership Interest In Subsidiary 6 month 49.00%.
- 2023-11-21: Proportion Of Ownership Interest In Subsidiary 51.00%.
| Period end | Proportion Of Ownership Interest In Subsidiary | Proportion Of Ownership Interest In Subsidiary 6 month |
|---|---|---|
| 2024-06-30 | 49.00% 6-K · filed 2024-09-24 | |
| 2023-11-21 | 51.00% 20-F · filed 2025-04-30 |